Board Member
Madrigal Pharmaceuticals, Inc. (MDGL)Equibles does not estimate personal net worth.
Get an email with a short summary when Madrigal Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get MDGL alertsPaul Friedman is recorded as Board Member at Madrigal Pharmaceuticals, Inc. (MDGL). The newest filing on record that lists Paul Friedman as Board Member at Madrigal Pharmaceuticals, Inc. (MDGL) is dated April 28, 2026. The proxy statement of Madrigal Pharmaceuticals, Inc. reports total compensation of $9,563,286 for Paul Friedman in fiscal 2023, including a base salary of $498,846. Disclosed compensation is on record for 7 fiscal years. Paul Friedman has spoken on 1 earnings call across 1 company, most recently for Madrigal Pharmaceuticals, Inc. on May 9, 2022. Madrigal Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Madrigal Pharmaceuticals, Inc. includes Bill Sibold (CEO and Board Member), Julian C. Baker (Chairman and Board Member), Mardi Dier (CFO) and 7 others.
“Here's the fine print dealing with our forward-looking statements. Please see today's press release and our SEC filings for forward-looking statement and risk factor considerations associated with these statements and our business.”
Start not stated–present
Last confirmed April 28, 2026
Start not stated–2024-04-29
Last confirmed by a filing; no departure on record
Biotechnology · Healthcare
Board Member
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Madrigal Pharmaceuticals, Inc. (MDGL) | Former Chief Executive Officer | $498,846 | $9,563,286 |
| 2022 | Madrigal Pharmaceuticals, Inc. (MDGL) | Former Chief Executive Officer | $658,021 | $5,395,385 |
| 2021 | Madrigal Pharmaceuticals, Inc. (MDGL) | Former Chief Executive Officer | $627,650 | $5,318,389 |
| 2020 | Madrigal Pharmaceuticals, Inc. (MDGL) | Chairman and Chief Executive Officer | $603,500 | $4,535,446 |
| 2019 | Madrigal Pharmaceuticals, Inc. (MDGL) | Chairman and Chief Executive Officer | $584,000 | $6,093,192 |
| 2018 | Madrigal Pharmaceuticals, Inc. (MDGL) | Chairman and Chief Executive Officer | $416,666 | $5,628,666 |
| 2017 | Madrigal Pharmaceuticals, Inc. (MDGL) | Chairman and Chief Executive Officer | $400,000 | $1,364,982 |
